Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. 01672
01672 logo

01672 News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

01672 News

S Korean Investors' Top HK Stock Purchase This Year: MINIMAX, Totaling USD 20.7M

Feb 13 2026aastocks

ASCLETIS-B Unveils 4% Discounted Share Placement Aiming to Raise HKD835 Million

Feb 03 2026aastocks

HSI Closes Down 331 Points Amid Weakness in Chip and Chinese Developer Stocks; Chinese Biotechs Show Steady Gains

Dec 09 2025aastocks

Citi Research: Phase 2a Results of ASCLETIS-B's ASC30 Highlight Best-in-Class Potential and Enhanced Tolerability

Dec 09 2025aastocks

ASCLETIS-B Rises 22% Following Positive Results of GLP-1 Drug ASC30 in Obesity Treatment Trial

Dec 09 2025aastocks

G Sachs Provides ST Risk Assessment for Three Firm Types as US Expected to Increase Scrutiny on CN Innovative Drugs, Potentially Creating 'Headline Risks' for CN Pharmaceutical Companies

Sep 11 2025aastocks

HSI Rises 48 Points at Midday; SINO BIOPHARM Drops Over 6%; EAST BUY Increases by 10%

Aug 19 2025aastocks

ASCLETIS-B Declines Approximately 10% at Opening After Securing $470M Through 9.9% Discounted Share Placement

Aug 19 2025aastocks

01672 Events

No data

No data

01672 Monitor News

No data

No data

01672 Earnings Analysis

No Data

No Data

People Also Watch